The BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed) funding from the National Institutes of Health (NIH) supports dissemination facilities for scaled-up production and distribution of a specific set of brain cell type-specific access reagents to study circuit function. Production and Distribution Facilities will be supported to disseminate hundreds of reagents specifically from Reagent Resource for Design and Development projects developed under RFA-MH-25-100. Applications are open to researchers in the USA.
The award provides up to 2.4 million USD per year (plus indirect costs) for up to 5 years.
Opportunity ID: RFA-MH-25-105
Letters of intent are due: June 1, 2026. Full applications are due: July 1, 2026.